Todd C. Brady

Director & President and CEO

Director & President and CEO at Aldeyra Therapeutics, Inc., filing insider transactions on 2026-06-03.

Total Purchases

$418K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-06-03

Last: 2026-06-03

Companies

Aldeyra Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-03	ALDX	Purchase	250.0K	$1.67	$418K	1.72M	SEC ↗